Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 106

1.

Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres.

Marin B, Beghi E, Vial C, Bernard E, Lautrette G, Clavelou P, Guy N, Lemasson G, Debruxelles S, Cintas P, Antoine JC, Camdessanche JP, Logroscino G, Preux PM, Couratier P; EURECALS consortium.

Eur J Neurol. 2016 Feb 1. doi: 10.1111/ene.12941. [Epub ahead of print]

PMID:
26833536
2.

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.

Barbin L, Rousseau C, Jousset N, Casey R, Debouverie M, Vukusic S, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Créange A, Labauge P, Magy L, Defer G, Foucher Y, Laplaud DA; CFSEP and OFSEP groups.

Neurology. 2016 Jan 29. pii: 10.1212/WNL.0000000000002395. [Epub ahead of print]

PMID:
26826205
3.

Seronegative Lyme neuroborreliosis in a patient treated by rituximab.

Gampourou F, Taithe F, Moisset X, Clavelou P.

Rev Neurol (Paris). 2015 Aug 26. pii: S0035-3787(15)00794-8. doi: 10.1016/j.neurol.2015.06.009. [Epub ahead of print] No abstract available.

PMID:
26318890
4.

Is there pain with neuropathic characteristics in patients with amyotrophic lateral sclerosis? A cross-sectional study.

Moisset X, Cornut-Chauvinc C, Clavelou P, Pereira B, Dallel R, Guy N.

Palliat Med. 2015 Aug 12. pii: 0269216315600332. [Epub ahead of print]

PMID:
26269326
5.

Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability.

Zéphir H, Bernard-Valnet R, Lebrun C, Outteryck O, Audoin B, Bourre B, Pittion S, Wiertlewski S, Ouallet JC, Neau JP, Ciron J, Clavelou P, Marignier R, Brassat D.

J Neurol. 2015 Oct;262(10):2329-35. doi: 10.1007/s00415-015-7852-y. Epub 2015 Jul 21.

PMID:
26194198
6.

Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.

Leray E, Vukusic S, Debouverie M, Clanet M, Brochet B, de Sèze J, Zéphir H, Defer G, Lebrun-Frenay C, Moreau T, Clavelou P, Pelletier J, Berger E, Cabre P, Camdessanché JP, Kalson-Ray S, Confavreux C, Edan G.

PLoS One. 2015 Jul 6;10(7):e0132033. doi: 10.1371/journal.pone.0132033. eCollection 2015.

7.

Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.

Planche V, Gibelin M, Cregut D, Pereira B, Clavelou P.

Eur J Neurol. 2016 Feb;23(2):282-9. doi: 10.1111/ene.12715. Epub 2015 Apr 22.

PMID:
25903918
8.

A novel autosomal dominant leukodystrophy with specific MRI pattern.

Corlobé A, Taithe F, Clavelou P, Pierre E, Carra-Dallière C, Ayrignac X, Mouzat K, Lumbroso S, Menjot de Champfleur N, Koenig M, Boespflug-Tanguy O, Labauge P.

J Neurol. 2015;262(4):988-91. doi: 10.1007/s00415-015-7660-4. Epub 2015 Feb 17.

PMID:
25683759
9.

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.

Ayrignac X, Carra-Dalliere C, Menjot de Champfleur N, Denier C, Aubourg P, Bellesme C, Castelnovo G, Pelletier J, Audoin B, Kaphan E, de Seze J, Collongues N, Blanc F, Chanson JB, Magnin E, Berger E, Vukusic S, Durand-Dubief F, Camdessanche JP, Cohen M, Lebrun-Frenay C, Brassat D, Clanet M, Vermersch P, Zephir H, Outteryck O, Wiertlewski S, Laplaud DA, Ouallet JC, Brochet B, Goizet C, Debouverie M, Pittion S, Edan G, Deburghgraeve V, Le Page E, Verny C, Amati-Bonneau P, Bonneau D, Hannequin D, Guyant-Maréchal L, Derache N, Defer GL, Moreau T, Giroud M, Guennoc AM, Clavelou P, Taithe F, Mathis S, Neau JP, Magy L, Devoize JL, Bataillard M, Masliah-Planchon J, Dorboz I, Tournier-Lasserve E, Levade T, Boespflug Tanguy O, Labauge P.

Brain. 2015 Feb;138(Pt 2):284-92. doi: 10.1093/brain/awu353. Epub 2014 Dec 19.

10.

Prolonged continuous theta-burst stimulation is more analgesic than 'classical' high frequency repetitive transcranial magnetic stimulation.

Moisset X, Goudeau S, Poindessous-Jazat F, Baudic S, Clavelou P, Bouhassira D.

Brain Stimul. 2015 Jan-Feb;8(1):135-41. doi: 10.1016/j.brs.2014.10.006. Epub 2014 Oct 18.

PMID:
25456979
11.

Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations.

Böhm J, Biancalana V, Malfatti E, Dondaine N, Koch C, Vasli N, Kress W, Strittmatter M, Taratuto AL, Gonorazky H, Laforêt P, Maisonobe T, Olivé M, Gonzalez-Mera L, Fardeau M, Carrière N, Clavelou P, Eymard B, Bitoun M, Rendu J, Fauré J, Weis J, Mandel JL, Romero NB, Laporte J.

Brain. 2014 Dec;137(Pt 12):3160-70. doi: 10.1093/brain/awu272. Epub 2014 Sep 25.

12.

Soluble IL-2 receptor: a biomarker for assessing myositis activity.

Tournadre A, Dubost JJ, Soubrier M, Ruivard M, Souteyrand P, Schmidt J, Clavelou P, Tridon A, Ristori JM.

Dis Markers. 2014;2014:472624. doi: 10.1155/2014/472624. Epub 2014 Feb 4.

13.

Two cases of bilateral amiodarone-associated optic neuropathy.

Chassang B, Bonnin N, Moisset X, Citron B, Clavelou P, Chiambaretta F.

J Fr Ophtalmol. 2014 Mar;37(3):231-6. doi: 10.1016/j.jfo.2013.12.004. Epub 2014 Feb 24.

14.

Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective study.

Cohen M, Maillart E, Tourbah A, De Sèze J, Vukusic S, Brassat D, Anne O, Wiertlewski S, Camu W, Courtois S, Ruet A, Debouverie M, Le Page E, Casez O, Heinzlef O, Stankoff B, Bourre B, Castelnovo G, Rico A, Berger E, Camdessanche JP, Defer G, Clavelou P, Al Khedr A, Zephir H, Fromont A, Papeix C, Brochet B, Pelletier J, Lebrun C; Club Francophone de la Sclérose en Plaques Investigators.

JAMA Neurol. 2014 Apr;71(4):436-41. doi: 10.1001/jamaneurol.2013.6240.

PMID:
24566807
15.

Can we optimize our teams? Multidisciplinary care for multiple sclerosis.

Clavelou P.

Expert Rev Neurother. 2013 Dec;13(12 Suppl):39-44. doi: 10.1586/14737175.2013.865873. Review.

PMID:
24289841
16.

Migraine headaches and pain with neuropathic characteristics: comorbid conditions in patients with multiple sclerosis.

Moisset X, Ouchchane L, Guy N, Bayle DJ, Dallel R, Clavelou P.

Pain. 2013 Dec;154(12):2691-9. doi: 10.1016/j.pain.2013.07.050. Epub 2013 Aug 2.

PMID:
23911697
17.

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.

Outteryck O, Ongagna JC, Brochet B, Rumbach L, Lebrun-Frenay C, Debouverie M, Zéphir H, Ouallet JC, Berger E, Cohen M, Pittion S, Laplaud D, Wiertlewski S, Cabre P, Pelletier J, Rico A, Defer G, Derache N, Camu W, Thouvenot E, Moreau T, Fromont A, Tourbah A, Labauge P, Castelnovo G, Clavelou P, Casez O, Hautecoeur P, Papeix C, Lubetzki C, Fontaine B, Couturier N, Bohossian N, Clanet M, Vermersch P, de Sèze J, Brassat D; BIONAT Network,; CFSEP.

Eur J Neurol. 2014;21(1):40-8. doi: 10.1111/ene.12204. Epub 2013 Jun 12.

PMID:
23895407
18.

Improvement of the management of infants, children and adults with a molecular diagnosis of Enterovirus meningitis during two observational study periods.

Archimbaud C, Ouchchane L, Mirand A, Chambon M, Demeocq F, Labbé A, Laurichesse H, Schmidt J, Clavelou P, Aumaître O, Regagnon C, Bailly JL, Henquell C, Peigue-Lafeuille H.

PLoS One. 2013 Jul 11;8(7):e68571. doi: 10.1371/journal.pone.0068571. Print 2013.

19.

Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.

Clavelou P, Blanquet M, Peyrol F, Ouchchane L, Gerbaud L.

J Neurol Sci. 2013 Aug 15;331(1-2):126-31. doi: 10.1016/j.jns.2013.06.002. Epub 2013 Jun 25.

PMID:
23809193
20.

Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy.

Léger JM, Viala K, Nicolas G, Créange A, Vallat JM, Pouget J, Clavelou P, Vial C, Steck A, Musset L, Marin B; RIMAG Study Group (France and Switzerland).

Neurology. 2013 Jun 11;80(24):2217-25. doi: 10.1212/WNL.0b013e318296e92b. Epub 2013 May 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk